BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1305865)

  • 1. [The activity of mitochondrial enzymes in the myocardium in chronic coronary failure during the administration of antianginal agents].
    Voronkov GS; Evstratova IN
    Eksp Klin Farmakol; 1992; 55(6):17-9. PubMed ID: 1305865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of mitochondrial creatine kinase isoenzyme and cardiac contractile function in experimental coronary failure].
    Voronkov GS; Orlova NN
    Patol Fiziol Eksp Ter; 1988; (1):55-7. PubMed ID: 3362592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glycerinated myocardiocyte fibers in the rat myocardium as one of the models in a preclinical assessment of antianginal agents].
    Dzhanpoladian EG; Sambelian VM; Kaĭfadzhian MA; Tatinian NG; Khoetsian EL
    Biull Eksp Biol Med; 1989 Apr; 107(4):444-6. PubMed ID: 2720162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of prolonged beta-adrenergic blockade on myocardial energy metabolism in coronary occlusion].
    Sysoliatina NA
    Farmakol Toksikol; 1982; 45(4):41-6. PubMed ID: 7128783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
    Kostin VI; Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional changes in the mitochondrial site of adenylate kinase and creatine kinase systems of energy transport induced by myocardial ischemia and adriablastin].
    Toleĭkis AI; Kal'venas AA; Dzheia PP; Prashkiavichius AK; Iasaĭtis AA
    Biokhimiia; 1988 Apr; 53(4):649-54. PubMed ID: 2840129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardioprotective effect of verapamil.
    Nayler WG; Slade AM
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():75-87. PubMed ID: 6956475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of certain biochemical changes in acute ischaemic rabbit heart by verapamil.
    Pandey G; Shukla R; Srimal RC; Dhawan BN
    Indian J Med Res; 1983 Feb; 77():248-54. PubMed ID: 6862551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of obzidan and isoptin on the indices of free-radical lipid peroxidation of the ischemic myocardium].
    Golovkin VD; Gukasov VM; Gatsura VV
    Farmakol Toksikol; 1988; 51(2):56-9. PubMed ID: 3378607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents].
    Sernov LN; Rozonov IuB; Gatsura VV
    Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium blocking agents of the verapamil series on the myocardium mitochondrial activity in experimentally induced arterial hypertension.
    Niţă V; Serban MG; Wawernia E
    Rom J Intern Med; 1992; 30(4):305-10. PubMed ID: 1299423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.
    Nayler WG; Ferrari R; Williams A
    Am J Cardiol; 1980 Aug; 46(2):242-8. PubMed ID: 7405836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of several membrane-bound creatine kinase isoenzymes in the rabbit myocardium in experimental disruption of coronary circulation].
    Voronkov GS
    Vopr Med Khim; 1984; 30(2):125-6. PubMed ID: 6740989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
    Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
    Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
    Tereshchenko VP; Nizhenkovskaia IV
    Vrach Delo; 1983 May; (5):19-21. PubMed ID: 6880160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective effect of coleonol on biochemical changes produced in coronary ligation induced ischemia.
    Kaul S; Singh V; Kapoor NK; Srimal RC
    Indian J Exp Biol; 1990 Oct; 28(10):981-4. PubMed ID: 2279771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural and biochemical alterations induced by propranolol treatment in experimental myocardial ischaemia.
    Laky D; Constantinescu S; Filipescu G; Constantinescu NM; Ratea E; Hălălău F
    Morphol Embryol (Bucur); 1981; 27(3):249-53. PubMed ID: 6460936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.